About TrialPath
Discover How TrialPath Clinical Advances Global Scientific Innovation
Who we are
TrialPath Clinical is a leading Contract Research Organization (CRO) advancing high-quality Phase I-IV clinical trials across Sub-Saharan Africa. We integrate ICH-GCP-compliant frameworks with region-specific regulatory and pharmacovigilance expertise to deliver efficient, data-driven clinical solutions for sponsors in pharmaceutical, biotechnology, and academic sectors. Our operations leverage advanced biostatistics, electronic data capture (EDC), and adaptive trial designs to accelerate Investigational New Drug (IND) and Clinical Trial Application (CTA) processes while maintaining the highest standards of quality, compliance, and patient safety.
Mission & Vision
Mission: To accelerate therapeutic development pipelines through precision-engineered clinical operations, including feasibility assessments, site qualification, and interim analyses that align with FDA, EMA, and WHO guidelines. We enable seamless translation from preclinical discovery to post-marketing surveillance.
Vision: To redefine clinical research in Africa by deploying scalable, technology-driven infrastructures, incorporating AI-augmented predictive analytics and decentralized trial modalities, to achieve efficiency, inclusivity, and scalability across diverse populations.
Core Competencies & Trajectory
Founded to address infrastructural and epidemiological gaps in African clinical landscapes, Our operations are underpinned by robust SOPs, CAPA frameworks, and a proven audit history with zero critical findings, demonstrating operational excellence.
We specialize in complex trial designs, adaptive methodologies, and multinational coordination, ensuring rigorous data integrity, compliance with 21 CFR Part 11, and statistically robust outcomes. Our approach enhances the reliability, generalizability, and timeliness of clinical data for our sponsors.
Expert Team
Our multidisciplinary team, comprising board-certified pharmacologists, biostatisticians, and regulatory strategists, brings 50+ person-years of cumulative GCP/GLP experience. Continuous professional development ensures alignment with evolving global standards, including ICH E6(R2), ICH M11, and digital health technologies for real-world evidence generation.Milestones & Ethical Commitment
TrialPath Clinical achieves accelerated enrollment rates—20-30% above industry benchmarks—through feasibility-driven site selection and efficient ethics committee submissions. We uphold the highest ethical standards, including informed consent per the Declaration of Helsinki, diversity in trial populations, and sustainable supply chain management for investigational products.Headquartered in Kampala, Uganda, TrialPath Clinical bridges global standards with localized clinical expertise, advancing therapeutic frontiers through rigorous, data-driven research.